Treatment of malignant pleural mesothelioma with carboplatin, liposomized doxorubicin, and gemcitabine: a phase II study

November 5, 2008 | Comments Off on Treatment of malignant pleural mesothelioma with carboplatin, liposomized doxorubicin, and gemcitabine: a phase II study

Journal of Thoracic Oncology. 2008 Nov;3(11):1325-31. [Link] Hillerdal G, Sorensen JB, Sundström S, Riska H, Vikström A, Hjerpe A. Department of Lung Medicine and Allergology, Karolinska University Hospital, Solna, Stockholm,…

Polyneuropathy in a patient with malignant pleural mesothelioma: a paraneoplastic syndrome

November 5, 2008 | Comments Off on Polyneuropathy in a patient with malignant pleural mesothelioma: a paraneoplastic syndrome

Journal of Thoracic Oncology. 2008 Nov;3(11):1359-60. [Link] Bech C, Sørensen JB. Department of Oncology, Finsen Centre, National University Hospital, Copenhagen, Denmark. cecilia.bech@rh.regionh.dk Abstract Paraneoplastic syndromes have only been reported in…

Cytopathologic differential diagnosis of malignant mesothelioma, adenocarcinoma and reactive mesothelial cells: A logistic regression analysis

November 1, 2008 | Comments Off on Cytopathologic differential diagnosis of malignant mesothelioma, adenocarcinoma and reactive mesothelial cells: A logistic regression analysis

Diagnostic Cytopathology. 2009 Jan;37(1):4-10. [Link] Cakir E, Demirag F, Aydin M, Unsal E. Department of Pathology, Ankara Ataturk Chest Diseases and Chest Surgery Education and Research Hospital, Ankara, Turkey. arabaci.ebru@gmail.com…

Genomic events associated with progression of pleural malignant mesothelioma

November 1, 2008 | Comments Off on Genomic events associated with progression of pleural malignant mesothelioma

International Journal of Cancer. 2009 Feb 1;124(3):589-99. [Link] Ivanov SV, Miller J, Lucito R, Tang C, Ivanova AV, Pei J, Carbone M, Cruz C, Beck A, Webb C, Nonaka D,…

Pemetrexed combined with paclitaxel: a dose-finding study evaluating three schedules in solid tumors

October 31, 2008 | Comments Off on Pemetrexed combined with paclitaxel: a dose-finding study evaluating three schedules in solid tumors

Investigational New Drugs. 2008 Oct 28. [Epub ahead of print] [Link] Hanauske AR, Dumez H, Piccart M, Yilmaz E, Graefe T, Gil T, Simms L, Musib L, Awada A. St.…

Diffuse malignant pleural mesothelioma: A multi-institutional clinicopathological study

October 31, 2008 | Comments Off on Diffuse malignant pleural mesothelioma: A multi-institutional clinicopathological study

Surgery Today. 2008;38(11):993-8. Epub 2008 Oct 29. [Link] Iyoda A, Yusa T, Kadoyama C, Sasaki K, Kimura H, Yamakawa H, Shiba M, Fujisawa T, Yoshino I. Department of Thoracic Surgery,…

Crocidolite and Mesothelioma

October 31, 2008 | Comments Off on Crocidolite and Mesothelioma

Ultrastructural Pathology. 2008 Sep-Oct;32(5):171-7. [Link] Schneider F, Sporn TA, Roggli VL. Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710, USA. frank.schneider@duke.edu Abstract This study reports changes in…

Semi-rigid thoracoscopy for undiagnosed exudative pleural effusions: a comparative study

October 31, 2008 | Comments Off on Semi-rigid thoracoscopy for undiagnosed exudative pleural effusions: a comparative study

Chinese Medical Journal. 2008 Aug 5;121(15):1384-9. [Link] Wang Z, Tong ZH, Li HJ, Zhao TT, Li XY, Xu LL, Luo J, Jin ML, Li RS, Wang C. Department of Respiratory…

The mortality of women exposed environmentally and domestically to blue asbestos at Wittenoom, Western Australia

October 23, 2008 | Comments Off on The mortality of women exposed environmentally and domestically to blue asbestos at Wittenoom, Western Australia

Occupational and Environmental Medicine. 2008 Nov;65(11):743-9. [Link] Reid A, Heyworth J, de Klerk N, Musk AW. Occupational Respiratory Epidemiology, School of Population Health, M431, University of Western Australia, 35 Stirling…

US mesothelioma patterns 1973-2002: indicators of change and insights into background rates

October 23, 2008 | Comments Off on US mesothelioma patterns 1973-2002: indicators of change and insights into background rates

European Journal of Cancer Prevention. 2008 Nov;17(6):525-34. [Link] Teta MJ, Mink PJ, Lau E, Sceurman BK, Foster ED. Exponent Inc., Health Sciences Practice, New York, New York, USA. jteta@exponent.com Abstract…

Categories